JEVTANA 60 mg concentrate and solvent for solution for infusion.
Phase 3 small_molecule active
Quick answer
JEVTANA 60 mg concentrate and solvent for solution for infusion. for Patients with localized prostate cancer and high-risk features of relapse. is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Patients with localized prostate cancer and high-risk features of relapse.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active